Roland Rott - Jan 3, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Ultrasound
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 07:40 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common stock, par value $0.01 per share Award +245 245 Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +643 643 Jan 4, 2023 Common stock, par value $0.01 per share 643 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +735 735 Jan 4, 2023 Common stock, par value $0.01 per share 735 $135.92 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +552 552 Jan 4, 2023 Common stock, par value $0.01 per share 552 $161.30 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +919 919 Jan 4, 2023 Common stock, par value $0.01 per share 919 $99.21 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +13.8K 13.8K Jan 4, 2023 Common stock, par value $0.01 per share 13.8K $88.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +1.64K 1.64K Jan 4, 2023 Common stock, par value $0.01 per share 1.64K $76.66 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +2.3K 2.3K Jan 4, 2023 Common stock, par value $0.01 per share 2.3K $76.66 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +13.3K 13.3K Jan 4, 2023 Common stock, par value $0.01 per share 13.3K $40.40 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +3.73K 3.73K Jan 4, 2023 Common stock, par value $0.01 per share 3.73K $57.74 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +1.61K 1.61K Jan 4, 2023 Common stock, par value $0.01 per share 1.61K $51.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +7.21K 7.21K Jan 4, 2023 Common stock, par value $0.01 per share 7.21K $63.51 Direct F1, F3
transaction GEHC Employee Stock Option (right to buy) Award +8.54K 8.54K Jan 4, 2023 Common stock, par value $0.01 per share 8.54K $75.24 Direct F1, F4
transaction GEHC Restricted Stock Units Award +1.08K 1.08K Jan 4, 2023 Common stock, par value $0.01 per share 1.08K Direct F1, F5, F6
transaction GEHC Restricted Stock Units Award +6.52K 6.52K Jan 4, 2023 Common stock, par value $0.01 per share 6.52K Direct F1, F5, F7
transaction GEHC Restricted Stock Units Award +3.71K 3.71K Jan 4, 2023 Common stock, par value $0.01 per share 3.71K Direct F1, F5, F8
transaction GEHC Restricted Stock Units Award +3.35K 3.35K Jan 4, 2023 Common stock, par value $0.01 per share 3.35K Direct F1, F5, F9
transaction GEHC Restricted Stock Units Award +5.83K 5.83K Jan 4, 2023 Common stock, par value $0.01 per share 5.83K Direct F1, F5, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.
F4 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on April 1, 2023 and 50% will become exercisable on April 1, 2024.
F5 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F6 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
F7 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.
F8 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F9 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024.
F10 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.